AstraZeneca’s Ultomiris Nears EU Green Light For NMOSD

After Positive CHMP Opinion

Set of traffic lights against a bright blue sky, green light illuminated
Sales Of Ultomiris Are Growing As The Soliris Franchise Declines • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Rare Diseases

More from Scrip